Proton imaging of siloxanes to map tissue oxygenation levels (PISTOL): a tool for quantitative tissue oximetry.

PubWeight™: 0.97‹?› | Rank: Top 15%

🔗 View Article (PMC 3027221)

Published in NMR Biomed on October 01, 2008

Authors

Vikram D Kodibagkar1, Xianghui Wang, Jesús Pacheco-Torres, Praveen Gulaka, Ralph P Mason

Author Affiliations

1: Cancer Imaging Program, Department of Radiology, University of Texas Southwestern Medical Center, Dallas, TX, USA.

Articles citing this

Comparison of 1H blood oxygen level-dependent (BOLD) and 19F MRI to investigate tumor oxygenation. Magn Reson Med (2009) 1.10

Magnetic resonance spectroscopy in metabolic and molecular imaging and diagnosis of cancer. Chem Rev (2010) 1.06

Hypoxic stress and cancer: imaging the axis of evil in tumor metastasis. NMR Biomed (2011) 1.06

New frontiers and developing applications in 19F NMR. Prog Nucl Magn Reson Spectrosc (2012) 1.02

Near infrared luminescent oxygen nanosensors with nanoparticle matrix tailored sensitivity. Anal Chem (2010) 0.99

Multimodality imaging of hypoxia in preclinical settings. Q J Nucl Med Mol Imaging (2010) 0.98

A review of responsive MRI contrast agents: 2005-2014. Contrast Media Mol Imaging (2014) 0.98

Lifetime-based photoacoustic oxygen sensing in vivo. J Biomed Opt (2012) 0.95

Dual-modality, dual-functional nanoprobes for cellular and molecular imaging. Theranostics (2012) 0.86

Dynamic oxygen challenge evaluated by NMR T1 and T2*--insights into tumor oxygenation. NMR Biomed (2015) 0.84

GdDO3NI, a nitroimidazole-based T1 MRI contrast agent for imaging tumor hypoxia in vivo. J Biol Inorg Chem (2013) 0.81

O2 -sensitive MRI distinguishes brain tumor versus radiation necrosis in murine models. Magn Reson Med (2015) 0.80

1H chemical shift magnetic resonance imaging probes with high sensitivity for multiplex imaging. Contrast Media Mol Imaging (2012) 0.77

Developing oxygen-enhanced magnetic resonance imaging as a prognostic biomarker of radiation response. Cancer Lett (2016) 0.76

Siloxane Nanoprobes for Labeling and Dual Modality Functional Imaging of Neural Stem Cells. Ann Biomed Eng (2015) 0.75

Assessing Tumor Oxygenation for Predicting Outcome in Radiation Oncology: A Review of Studies Correlating Tumor Hypoxic Status and Outcome in the Preclinical and Clinical Settings. Front Oncol (2017) 0.75

Articles cited by this

The concentration of oxygen dissolved in tissues at the time of irradiation as a factor in radiotherapy. Br J Radiol (1953) 12.04

Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck. Int J Radiat Oncol Biol Phys (1997) 4.55

Oxygenation of human tumors: evaluation of tissue oxygen distribution in breast cancers by computerized O2 tension measurements. Cancer Res (1991) 4.12

Hypoxia: importance in tumor biology, noninvasive measurement by imaging, and value of its measurement in the management of cancer therapy. Int J Radiat Biol (2006) 3.98

1H NMR chemical shift selective (CHESS) imaging. Phys Med Biol (1985) 3.91

Tumor hypoxia has independent predictor impact only in patients with node-negative cervix cancer. J Clin Oncol (2002) 2.82

Pimonidazole binding and tumor vascularity predict for treatment outcome in head and neck cancer. Cancer Res (2002) 1.95

19F: a versatile reporter for non-invasive physiology and pharmacology using magnetic resonance. Curr Med Chem (2005) 1.79

Comparative measurements of hypoxia in human brain tumors using needle electrodes and EF5 binding. Cancer Res (2004) 1.59

Issues in flow and oxygenation dependent contrast (FLOOD) imaging of tumours. NMR Biomed (2001) 1.48

Comparison of skeletal muscle PO2, PCO2, and pH with gastric tonometric P(CO2) and pH in hemorrhagic shock. Crit Care Med (1999) 1.45

Rapid tissue oxygen tension mapping using 19F inversion-recovery echo-planar imaging of perfluoro-15-crown-5-ether. Magn Reson Med (1994) 1.45

Hypoxic prostate/muscle pO2 ratio predicts for biochemical failure in patients with prostate cancer: preliminary findings. Urology (2002) 1.37

Measuring changes in tumor oxygenation. Methods Enzymol (2004) 1.30

Tumor oximetry: demonstration of an enhanced dynamic mapping procedure using fluorine-19 echo planar magnetic resonance imaging in the Dunning prostate R3327-AT1 rat tumor. Int J Radiat Oncol Biol Phys (2001) 1.26

MR assessment of changes of tumor in response to hyperbaric oxygen treatment. Magn Reson Med (2006) 1.21

Changes in oxygenation of intracranial tumors with carbogen: a BOLD MRI and EPR oximetry study. J Magn Reson Imaging (2002) 1.16

Tumor oxygen dynamics: correlation of in vivo MRI with histological findings. Neoplasia (2003) 1.15

Non-invasive determination of tumor oxygen tension and local variation with growth. Int J Radiat Oncol Biol Phys (1994) 1.09

Hexafluorobenzene: a sensitive 19F NMR indicator of tumor oxygenation. NMR Biomed (1996) 1.07

Correlation of tumor oxygen dynamics with radiation response of the dunning prostate R3327-HI tumor. Radiat Res (2003) 1.04

Long-term performance of interstial fluid pressure and hypoxia as prognostic factors in cervix cancer. Radiother Oncol (2006) 1.03

Novel 1H NMR approach to quantitative tissue oximetry using hexamethyldisiloxane. Magn Reson Med (2006) 1.03

Noninvasive oxygen partial pressure measurement of human body fluids in vivo using magnetic resonance imaging. Acad Radiol (2006) 1.03

Polarographic needle electrode measurements of oxygen in rat prostate carcinomas: accuracy and reproducibility. Int J Radiat Oncol Biol Phys (1995) 1.02

Effect on regrowth delay in a murine tumor of scheduling split-dose irradiation based on direct pO2 measurements by electron paramagnetic resonance oximetry. Radiat Res (1998) 0.98

Correlation of radiation response with tumor oxygenation in the Dunning prostate R3327-AT1 tumor. Int J Radiat Oncol Biol Phys (2007) 0.97

Differential oxygen dynamics in two diverse Dunning prostate R3327 rat tumor sublines (MAT-Lu and HI) with respect to growth and respiratory challenge. Int J Radiat Oncol Biol Phys (2002) 0.94

Regional tumor oximetry: 19F NMR spectroscopy of hexafluorobenzene. Int J Radiat Oncol Biol Phys (1998) 0.94

Physical principles of quantitative nuclear magnetic resonance oximetry. Front Biosci (2008) 0.93

Current issues in the utility of 19F nuclear magnetic resonance methodologies for the assessment of tumour hypoxia. Philos Trans R Soc Lond B Biol Sci (2004) 0.88

Closed-chamber inhalation pharmacokinetic studies with hexamethyldisiloxane in the rat. Inhal Toxicol (2003) 0.86

Non-invasive physiology: 19F NMR of perfluorocarbons. Artif Cells Blood Substit Immobil Biotechnol (1994) 0.84

Metabolites of hexamethyldisiloxane and decamethylcyclopentasiloxane in Fischer 344 rat urine--a comparison of a linear and a cyclic siloxane. Drug Metab Dispos (2003) 0.84

In vivo and in vitro EPR oximetry with fusinite: a new coal-derived, particulate EPR probe. Magn Reson Med (1994) 0.83

Encapsulation of a highly sensitive EPR active oxygen probe into sonochemically prepared microspheres. J Phys Chem B (2007) 0.83

Oxygen tension mapping with F-19 echo-planar MR imaging of sequestered perfluorocarbon. J Magn Reson Imaging (1994) 0.82

Hexamethyidisiloxane: A 13-week subchronic whole-body vapor inhalation toxicity study in Fischer 344 rats. Int J Toxicol (2002) 0.81

19F NMR imaging of blood oxygenation in the brain. Magn Reson Med (1988) 0.80

Articles by these authors

Early inactivation of p53 tumor suppressor gene cooperating with NF1 loss induces malignant astrocytoma. Cancer Cell (2005) 5.51

Pten haploinsufficiency accelerates formation of high-grade astrocytomas. Cancer Res (2008) 3.99

Hypoxia: importance in tumor biology, noninvasive measurement by imaging, and value of its measurement in the management of cancer therapy. Int J Radiat Biol (2006) 3.98

Molecular imaging of hypoxia. J Nucl Med (2008) 2.61

19F: a versatile reporter for non-invasive physiology and pharmacology using magnetic resonance. Curr Med Chem (2005) 1.79

Validating bioluminescence imaging as a high-throughput, quantitative modality for assessing tumor burden. Mol Imaging (2004) 1.65

Biodistribution of phosphodiester and phosphorothioate siRNA. Bioorg Med Chem Lett (2004) 1.57

Development of aliphatic biodegradable photoluminescent polymers. Proc Natl Acad Sci U S A (2009) 1.54

On the potential for molecular imaging with Cerenkov luminescence. Opt Lett (2010) 1.33

Measuring changes in tumor oxygenation. Methods Enzymol (2004) 1.30

Antivascular effects of combretastatin A4 phosphate in breast cancer xenograft assessed using dynamic bioluminescence imaging and confirmed by MRI. FASEB J (2008) 1.26

Vascular imaging of solid tumors in rats with a radioactive arsenic-labeled antibody that binds exposed phosphatidylserine. Clin Cancer Res (2008) 1.23

Dynamic near-infrared optical imaging of 2-deoxyglucose uptake by intracranial glioma of athymic mice. PLoS One (2009) 1.18

Tumor physiologic response to combretastatin A4 phosphate assessed by MRI. Int J Radiat Oncol Biol Phys (2005) 1.16

Tumor oxygen dynamics: correlation of in vivo MRI with histological findings. Neoplasia (2003) 1.15

Comparison of 1H blood oxygen level-dependent (BOLD) and 19F MRI to investigate tumor oxygenation. Magn Reson Med (2009) 1.10

Novel NMR approach to assessing gene transfection: 4-fluoro-2-nitrophenyl-beta-D-galactopyranoside as a prototype reporter molecule for beta-galactosidase. Magn Reson Med (2004) 1.07

Correlations of noninvasive BOLD and TOLD MRI with pO2 and relevance to tumor radiation response. Magn Reson Med (2013) 1.04

Correlation of tumor oxygen dynamics with radiation response of the dunning prostate R3327-HI tumor. Radiat Res (2003) 1.04

Novel 1H NMR approach to quantitative tissue oximetry using hexamethyldisiloxane. Magn Reson Med (2006) 1.03

Tumour oxygen dynamics measured simultaneously by near-infrared spectroscopy and 19F magnetic resonance imaging in rats. Phys Med Biol (2005) 1.03

Blood oxygenation level-dependent (BOLD) contrast magnetic resonance imaging (MRI) for prediction of breast cancer chemotherapy response: a pilot study. J Magn Reson Imaging (2012) 1.02

The use of histone deacetylase inhibitor FK228 and DNA hypomethylation agent 5-azacytidine in human bladder cancer therapy. Int J Cancer (2007) 1.02

Imaging beta-galactosidase activity using 19F chemical shift imaging of LacZ gene-reporter molecule 2-fluoro-4-nitrophenol-beta-D-galactopyranoside. Magn Reson Imaging (2006) 1.02

New frontiers and developing applications in 19F NMR. Prog Nucl Magn Reson Spectrosc (2012) 1.02

Novel NMR platform for detecting gene transfection: synthesis and evaluation of fluorinated phenyl beta-D-galactosides with potential application for assessing LacZ gene expression. Bioconjug Chem (2004) 1.01

Near-infrared spectroscopy and imaging of tumor vascular oxygenation. Methods Enzymol (2004) 1.01

Imaging beta-galactosidase activity in human tumor xenografts and transgenic mice using a chemiluminescent substrate. PLoS One (2010) 0.99

Synthesis and evaluation of novel enhanced gene reporter molecules: detection of beta-galactosidase activity using 19F NMR of trifluoromethylated aryl beta-D-galactopyranosides. Bioorg Med Chem (2005) 0.99

S-Gal, a novel 1H MRI reporter for beta-galactosidase. Magn Reson Med (2010) 0.98

Interplay of tumor vascular oxygenation and tumor pO2 observed using near-infrared spectroscopy, an oxygen needle electrode, and 19F MR pO2 mapping. J Biomed Opt (2003) 0.97

Correlation of radiation response with tumor oxygenation in the Dunning prostate R3327-AT1 tumor. Int J Radiat Oncol Biol Phys (2007) 0.97

High-throughput quantitative bioluminescence imaging for assessing tumor burden. Methods Mol Biol (2009) 0.97

Synthesis of a 2-aryl-3-aroyl indole salt (OXi8007) resembling combretastatin A-4 with application as a vascular disrupting agent. J Nat Prod (2013) 0.95

Development of intrinsically photoluminescent and photostable polylactones. Adv Mater (2014) 0.94

Oxygenation in cervical cancer and normal uterine cervix assessed using blood oxygenation level-dependent (BOLD) MRI at 3T. NMR Biomed (2012) 0.94

Dynamic response of breast tumor oxygenation to hyperoxic respiratory challenge monitored with three oxygen-sensitive parameters. Appl Opt (2003) 0.94

Differential oxygen dynamics in two diverse Dunning prostate R3327 rat tumor sublines (MAT-Lu and HI) with respect to growth and respiratory challenge. Int J Radiat Oncol Biol Phys (2002) 0.94

Exploring feasibility of multicolored CdTe quantum dots for in vitro and in vivo fluorescent imaging. J Nanosci Nanotechnol (2008) 0.94

Physical principles of quantitative nuclear magnetic resonance oximetry. Front Biosci (2008) 0.93

Synthesis and evaluation of a novel gene reporter molecule: detection of beta-galactosidase activity using 19F NMR of a fluorinated vitamin B6 conjugate+. Med Chem (2005) 0.93

A 19F-NMR approach using reporter molecule pairs to assess beta-galactosidase in human xenograft tumors in vivo. NMR Biomed (2008) 0.93

19F-NMR detection of lacZ gene expression via the enzymic hydrolysis of 2-fluoro-4-nitrophenyl beta-D-galactopyranoside in vivo in PC3 prostate tumor xenografts in the mouse. FASEB J (2007) 0.91

Comparison of BOLD contrast and Gd-DTPA dynamic contrast-enhanced imaging in rat prostate tumor. Magn Reson Med (2004) 0.91

Continuous low-dose (metronomic) chemotherapy on rat prostate tumors evaluated using MRI in vivo and comparison with histology. Neoplasia (2005) 0.90

A noninvasive tumor oxygenation imaging strategy using magnetic resonance imaging of endogenous blood and tissue water. Magn Reson Med (2014) 0.90

Comparison of optical and power Doppler ultrasound imaging for non-invasive evaluation of arsenic trioxide as a vascular disrupting agent in tumors. PLoS One (2012) 0.89

Self-eating and self-defense: autophagy controls innate immunity and adaptive immunity. J Leukoc Biol (2012) 0.88

Evaluation of red CdTe and near infrared CdHgTe quantum dots by fluorescent imaging. J Nanosci Nanotechnol (2008) 0.87

Synthesis and characterization of novel lacZ gene reporter molecules: detection of beta-galactosidase activity by 19F nuclear magnetic resonance of polyglycosylated fluorinated vitamin B6. J Med Chem (2006) 0.87

Tubulin-destabilizing agent BPR0L075 induces vascular-disruption in human breast cancer mammary fat pad xenografts. PLoS One (2012) 0.86

Dynamic breast tumor oximetry: the development of prognostic radiology. Technol Cancer Res Treat (2002) 0.86

In vitro and In vivo Assessment of CdTe and CdHgTe Toxicity and Clearance. J Biomed Nanotechnol (2008) 0.86

In vivo near-infrared spectroscopy and magnetic resonance imaging monitoring of tumor response to combretastatin A-4-phosphate correlated with therapeutic outcome. Int J Radiat Oncol Biol Phys (2011) 0.85

Molecular imaging in prostate cancer. J Cell Biochem (2003) 0.84

Free-breathing phase contrast MRI with near 100% respiratory navigator efficiency using k-space-dependent respiratory gating. Magn Reson Med (2013) 0.84

Simultaneous measurement of tissue oxygen level-dependent (TOLD) and blood oxygenation level-dependent (BOLD) effects in abdominal tissue oxygenation level studies. J Magn Reson Imaging (2013) 0.83

Dual 19F/1H MR gene reporter molecules for in vivo detection of β-galactosidase. Bioconjug Chem (2012) 0.83

Tunable optical and magneto-optical properties of ferrofluid in the terahertz regime. Opt Express (2014) 0.83

Modulation of TSC-mTOR signaling on immune cells in immunity and autoimmunity. J Cell Physiol (2014) 0.83

Terahertz ultrathin film thickness sensor below λ/90 based on metamaterial. Appl Opt (2016) 0.83

Novel Fe(3+)-Based (1)H MRI β-Galactosidase Reporter Molecules** Chempluschem (2012) 0.82

Inhibiting tumor growth of colorectal cancer by blocking the expression of vascular endothelial growth factor receptor 3 using interference vector-based RNA interference. Int J Mol Med (2010) 0.82

Dendritic MRI contrast agents: an efficient prelabeling approach based on CuAAC. Biomacromolecules (2011) 0.82

Phosphatidylserine-targeted molecular imaging of tumor vasculature by magnetic resonance imaging. J Biomed Nanotechnol (2014) 0.82

Podosome rings generate forces that drive saltatory osteoclast migration. Mol Biol Cell (2011) 0.81

GdDO3NI, a nitroimidazole-based T1 MRI contrast agent for imaging tumor hypoxia in vivo. J Biol Inorg Chem (2013) 0.81

Dynamic contrast enhanced fluorescent molecular imaging of vascular disruption induced by combretastatin-A4P in tumor xenografts. J Biomed Nanotechnol (2014) 0.81

Prevention of thiazide-induced hypokalemia without magnesium depletion by potassium-magnesium-citrate. Am J Ther (2006) 0.81

Quantitative tissue oxygen measurement in multiple organs using 19F MRI in a rat model. Magn Reson Med (2011) 0.81

Evaluation of intraoperative intraperitoneal cytology for advanced gastric carcinoma. Oncology (2002) 0.81

Upregulation of TRAG3 gene in urothelial carcinoma of the bladder. Int J Cancer (2010) 0.81

Rapid-growing juvenile xanthogranuloma: The reality of a second opinion teleconsultation. Letters to the editor. Australas J Dermatol (2010) 0.80

Serial non-invasive monitoring of renal disease following immune-mediated injury using near-infrared optical imaging. PLoS One (2012) 0.79

In vivo spectroscopic characterization of porcine biliary tract tissues: first step in the development of new biliary tract imaging devices. Ann Biomed Eng (2008) 0.79

Hexamethyldisiloxane-based nanoprobes for (1) H MRI oximetry. NMR Biomed (2011) 0.79

In vivo bioluminescence imaging of tumor hypoxia dynamics of breast cancer brain metastasis in a mouse model. J Vis Exp (2011) 0.78

Novel S-Gal(®) analogs as (1)H MRI reporters for in vivo detection of β-galactosidase. Magn Reson Imaging (2013) 0.78

Red-shifted emission from 1,2-dioxetane-based chemiluminescent reactions. Luminescence (2014) 0.77

Tumor oxygen dynamics: comparison of 19F MR EPI and frequency domain NIR spectroscopy. Adv Exp Med Biol (2003) 0.76

Structural interrogation of benzosuberene-based inhibitors of tubulin polymerization. Bioorg Med Chem (2015) 0.76

6-Trifluoromethylpyridoxine: novel (19)F NMR pH indicator for in vivo detection. J Med Chem (2012) 0.75

Mathematical modeling of tumor response to radiation: radio-sensitivity correlation with BOLD, TOLD, ΔR1 and ΔR2* investigated in large Dunning R3327-AT1 rat prostate tumors. Conf Proc IEEE Eng Med Biol Soc (2015) 0.75

[Incidence and mortality of thyroid cancer in six cancer registries of Zhejiang province, 2000-2009]. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi (2014) 0.75

[Research Progress in Black Queen Cell Virus Causing Disease]. Bing Du Xue Bao (2015) 0.75

[Isolation, Identification and Analysis of the Complete Genome Sequence of Black Queen Cell Virus Strain China-JL1]. Bing Du Xue Bao (2015) 0.75

Surface and bulk second-harmonic responses from a glass slide using tightly focused radially polarized light. Opt Lett (2016) 0.75

Incidence and mortality of laryngeal cancer in Zhejiang cancer registry, 2000-2011. J Cancer Res Ther (2015) 0.75

Sharper photonic nanojets generated by microspheres under higher-order radially polarized beam illumination. Appl Opt (2021) 0.75

Far-field radiation patterns of second harmonic generation from gold nanoparticles under tightly focused illumination. Opt Express (2016) 0.75

[Influence of the concentration of silver nanoparticles on the proliferation behavior of human umbilical vein endothelial cell and human umbilical artery smooth muscle cells]. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi (2010) 0.75

The Influence of Different Operating Conditions on the Blood Damage of a Pulsatile Ventricular Assist Device. ASAIO J (2015) 0.75

Terahertz isolator based on nonreciprocal magneto-metasurface. Opt Express (2015) 0.75